Increased susceptibility of Pseudomonas aeruginosa to macrolides and ketolides in eukaryotic cell culture media and biological fluids due to decreased expression of oprM and increased outer-membrane permeability.
about
Responses of Pseudomonas aeruginosa to antimicrobialsSubcellular Chemical Imaging of Antibiotics in Single Bacteria Using C60-Secondary Ion Mass Spectrometry.Evaluation of a FRET-peptide substrate to predict virulence in Pseudomonas aeruginosa.Azithromycin Synergizes with Cationic Antimicrobial Peptides to Exert Bactericidal and Therapeutic Activity Against Highly Multidrug-Resistant Gram-Negative Bacterial Pathogens.Standard susceptibility testing overlooks potent azithromycin activity and cationic peptide synergy against MDR Stenotrophomonas maltophilia.Antivirulence activity of azithromycin in Pseudomonas aeruginosaBacteriostatic versus bactericidal antibiotics for patients with serious bacterial infections: systematic review and meta-analysis.Pharmacokinetics and pharmacodynamics in antibiotic dose optimization.Impact of azithromycin on the clinical and antimicrobial effectiveness of tobramycin in the treatment of cystic fibrosis.New treatment options for lower respiratory tract infections.Salicylidene Acylhydrazides and Hydroxyquinolines Act as Inhibitors of Type Three Secretion Systems in Pseudomonas aeruginosa by Distinct Mechanisms.Antimicrobial and antifouling efficacy of urinary catheters impregnated with a combination of macrolide and fluoroquinolone antibiotics against Pseudomonas aeruginosa.Macrolides and β-lactam antibiotics enhance C3b deposition on the surface of multidrug-resistant Streptococcus pneumoniae strains by a LytA autolysin-dependent mechanism.Pharmacodynamic Evaluation and PK/PD-Based Dose Prediction of Tulathromycin: A Potential New Indication for Streptococcus suis Infection.Interaction of Antibiotics with Innate Host Defense Factors against Salmonella enterica Serotype Newport.Pharmacokinetics and Pharmacodynamics of Tildipirosin Against Pasteurella multocida in a Murine Lung Infection Model.
P2860
Q28305587-35FBCB74-0ECE-480A-A0C6-ED6759FF3D70Q33635077-5B4D3A20-C104-4AC5-9B7E-8B4C995EFE48Q35058581-3B894233-B9F4-48D9-BEAE-19C26FCA9310Q35947509-22E066FE-95F9-42D4-9C07-78E245E232A0Q36794786-BAFBF826-FC05-4E0B-83A6-315151576C5CQ38209321-3D00E2F1-50ED-4E08-97E5-4FD452ADA9C4Q38255278-3AE72E91-11E4-478F-BA1A-471101EEAD7DQ38664871-7CBBE170-C15D-4D4E-96E3-FA518F2E2CC7Q39063568-4DF3FB04-65FF-45A8-A3D0-6A9AC57A0EFDQ40111519-8D9DEAC2-CE7B-461D-9DE6-3FE3340BA0C0Q40257063-5039EFB7-644C-401D-9FDF-879BE377BC08Q40753082-2DB92B1B-DE8C-40D4-AA83-C30D5165F6CBQ41570386-F88AA566-27BF-40B1-8517-79545252AFA4Q42369923-77435A23-BB44-43B4-9C7C-D209B30E5C01Q46640942-9F92F37F-526A-48D2-995C-F151237ACE8EQ55364168-98D4FA5B-B19A-4893-A1C8-62CFDCDE03C8
P2860
Increased susceptibility of Pseudomonas aeruginosa to macrolides and ketolides in eukaryotic cell culture media and biological fluids due to decreased expression of oprM and increased outer-membrane permeability.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Increased susceptibility of Ps ...... d outer-membrane permeability.
@en
Increased susceptibility of Ps ...... d outer-membrane permeability.
@nl
type
label
Increased susceptibility of Ps ...... d outer-membrane permeability.
@en
Increased susceptibility of Ps ...... d outer-membrane permeability.
@nl
prefLabel
Increased susceptibility of Ps ...... d outer-membrane permeability.
@en
Increased susceptibility of Ps ...... d outer-membrane permeability.
@nl
P2093
P2860
P356
P1476
Increased susceptibility of Ps ...... d outer-membrane permeability.
@en
P2093
F Vanderbist
Julien M Buyck
Patrick Plésiat
P2860
P304
P356
10.1093/CID/CIS473
P407
P577
2012-05-09T00:00:00Z